CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE Drug Patent Profile

Which patents cover Candesartan Cilexetil And Hydrochlorothiazide, and when can generic versions of Candesartan Cilexetil And Hydrochlorothiazide launch?

Candesartan Cilexetil And Hydrochlorothiazide is a drug marketed by Apotex Inc, Dr Reddys Labs Ltd, Macleods Pharms Ltd, Mylan, Prinston Inc, and Zydus Lifesciences. and is included in six NDAs.

The generic ingredient in CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE is candesartan cilexetil; hydrochlorothiazide. There are twenty-two drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the candesartan cilexetil; hydrochlorothiazide profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Candesartan Cilexetil And Hydrochlorothiazide

A generic version of CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE was approved as candesartan cilexetil; hydrochlorothiazide by MYLAN on December 4^th, 2012.

Summary for CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE

US Patents:	0
Applicants:	6
NDAs:	6
Finished Product Suppliers / Packagers:	4
Clinical Trials:	6
What excipients (inactive ingredients) are in CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE?	CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE excipients list
DailyMed Link:	CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE at DailyMed

Recent Clinical Trials for CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
GlaxoSmithKline	Phase 1
Takeda	Phase 4
Takeda

See all CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE clinical trials

Pharmacology for CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE

Drug Class	Angiotensin 2 Receptor Blocker Thiazide Diuretic
Mechanism of Action	Angiotensin 2 Receptor Antagonists
Physiological Effect	Increased Diuresis

US Patents and Regulatory Information for CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Apotex Inc	CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE	candesartan cilexetil; hydrochlorothiazide	TABLET;ORAL	202884-001	Dec 4, 2012		DISCN	No	No
Zydus Lifesciences	CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE	candesartan cilexetil; hydrochlorothiazide	TABLET;ORAL	203466-003	Nov 27, 2017	AB	RX	No	No
Macleods Pharms Ltd	CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE	candesartan cilexetil; hydrochlorothiazide	TABLET;ORAL	204100-001	Feb 27, 2015	AB	RX	No	No
Dr Reddys Labs Ltd	CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE	candesartan cilexetil; hydrochlorothiazide	TABLET;ORAL	202965-001	Jun 3, 2013	AB	RX	No	No
Mylan	CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE	candesartan cilexetil; hydrochlorothiazide	TABLET;ORAL	090704-003	Dec 4, 2012	AB	RX	No	No
Macleods Pharms Ltd	CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE	candesartan cilexetil; hydrochlorothiazide	TABLET;ORAL	204100-002	Feb 27, 2015	AB	RX	No	No